0001127602-23-002332.txt : 20230126 0001127602-23-002332.hdr.sgml : 20230126 20230126173009 ACCESSION NUMBER: 0001127602-23-002332 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221228 FILED AS OF DATE: 20230126 DATE AS OF CHANGE: 20230126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MACKAY GEOFFREY CENTRAL INDEX KEY: 0001741849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38537 FILM NUMBER: 23558789 MAIL ADDRESS: STREET 1: C/O AVROBIO, INC. STREET 2: ONE KENDALL SQ, BLDG. 300, STE. 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVROBIO, Inc. CENTRAL INDEX KEY: 0001681087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 810710585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617.914.8420 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AvroBio, Inc. DATE OF NAME CHANGE: 20160729 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-12-28 0001681087 AVROBIO, Inc. AVRO 0001741849 MACKAY GEOFFREY C/O AVROBIO, INC. 100 TECHNOLOGY SQUARE, 6TH FLOOR CAMBRIDGE MA 02139 1 1 President & CEO Common Stock 2022-12-28 5 G 0 E 245123 0 D 142013 D Common Stock 2022-12-28 5 G 0 E 245123 0 A 445123 I By The Geoff R. MacKay Irrevocable Trust Common Stock 2023-01-24 4 M 0 45999 .91 A 188012 D Common Stock 72604 I By daughter of reporting person Common Stock 72604 I By son of reporting person Stock Option (Right to Buy) .91 2023-01-24 4 M 0 45999 0 D 2027-06-12 Common Stock 45999 0 D This transaction was a bona fide gift of common stock to The Geoff R. MacKay Irrevocable Trust. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. The shares were previously held in a custodial account for the Reporting Person's son, established pursuant to the Uniform Transfers to Minors Act ("UTMA"), for which the Reporting Person served as custodian. The shares have since been distributed to the Reporting Person's son, as required by the terms of the account upon the son attaining the age of 21. 54,453 shares were subsequently transferred to the Mac C. MacKay Irrevocable Trust on December 30, 2022. 25% of the shares vested on June 13, 2018, and the remaining 75% vested in equal monthly installments thereafter over a three-year period. /s/ Steven Avruch, Attorney-in-Fact for Geoffrey MacKay 2023-01-26